The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

Alan Pollack(University of Miami), Theodore Karrison(NRG Oncology), Alexander G. Balogh(University of Calgary), Leonard G. Gomella(Sidney Kimmel Cancer Center), Daniel A. Low(University of California, Los Angeles), Deborah Watkins Bruner(Emory University), Jeffrey S. Wefel(The University of Texas MD Anderson Cancer Center), André‐Guy Martin(Hôtel-Dieu de Québec), Jeff M. Michalski(Washington University in St. Louis), Steve Angyalfi(University of Calgary), Himanshu Lukka(McMaster University), Sergio Faria(McGill University Health Centre), George Rodrigues(Western University), Marie-Claude Beauchemin(Centre Hospitalier de l’Université de Montréal), R. Jeffrey Lee(Intermountain Medical Center), Samantha A. Seaward(Kaiser Permanente Vallejo Medical Center), Aaron M. Allen(Rabin Medical Center), Drew C. Monitto(Spartanburg Regional Medical Center), Wendy Seiferheld(NRG Oncology), Oliver Sartor(Tulane University), Felix Feng(University of California, San Francisco), Howard M. Sandler(Cedars-Sinai Medical Center)
The Lancet
May 1, 2022
Cited by 248Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis